PHARMAWINGS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMAWINGS
Largest movements
- Cash -€2,113
down €2,113 (-22.3%), from €9,454 to €7,341
mainly Net result for the year (-€2,082) and Trade debts (-€132)
- Receivables within one year -€165
no longer reported in 2025 (was €165)
- Profit (loss) carried forward -€2,082
down €2,082 (-69.1%), from -€3,013 to -€5,096
- Trade debts -€132
no longer reported in 2025 (was €132)
- Gross operating margin +€1,343
up €1,343 (+48.8%), from -€2,753 to -€1,409
- Other operating charges +€402
up €402 (+319%), from €126 to €528
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €9,619 | €7,404 | -€2,214 | -23.0% |
| Current assets | 29/58 | €9,619 | €7,404 | -€2,214 | -23.0% |
| Amounts receivable within one year | 40/41 | €165 | - | -€165 | |
| Other amounts receivable | 41 | €165 | - | -€165 | |
| Cash at bank and in hand | 54/58 | €9,454 | €7,341 | -€2,113 | -22.3% |
| Deferred charges and accrued income | 490/1 | - | €63 | +€63 | |
| Total equity and liabilities | 10/49 | €9,619 | €7,404 | -€2,214 | -23.0% |
| Equity | 10/15 | -€513 | -€2,596 | -€2,082 | -406% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€3,013 | -€5,096 | -€2,082 | -69.1% |
| Amounts payable | 17/49 | €10,132 | €10,000 | -€132 | -1.3% |
| Amounts payable within one year | 42/48 | €10,132 | €10,000 | -€132 | -1.3% |
| Trade debts | 44 | €132 | - | -€132 | |
| Suppliers | 440/4 | €132 | - | -€132 | |
| Other amounts payable | 47/48 | €10,000 | €10,000 | = | 0.0% |
| Other operating charges | 640/8 | €126 | €528 | +€402 | +319% |
| Gross operating margin | 9900 | -€2,753 | -€1,409 | +€1,343 | +48.8% |
| Operating profit (loss) | 9901 | -€2,879 | -€1,937 | +€942 | +32.7% |
| Financial charges | 65/66B | €135 | €145 | +€11 | +8.0% |
| Recurring financial charges | 65 | €135 | €145 | +€11 | +8.0% |
| Profit (loss) for the period before taxes | 9903 | -€3,013 | -€2,082 | +€931 | +30.9% |
| Profit (loss) for the period | 9904 | -€3,013 | -€2,082 | +€931 | +30.9% |
| Profit (loss) for the period to be appropriated | 9905 | -€3,013 | -€2,082 | +€931 | +30.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.